GR75287B - - Google Patents

Info

Publication number
GR75287B
GR75287B GR65613A GR810165613A GR75287B GR 75287 B GR75287 B GR 75287B GR 65613 A GR65613 A GR 65613A GR 810165613 A GR810165613 A GR 810165613A GR 75287 B GR75287 B GR 75287B
Authority
GR
Greece
Application number
GR65613A
Other languages
Greek (el)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of GR75287B publication Critical patent/GR75287B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/26—Radicals substituted by carbon atoms having three bonds to hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
GR65613A 1980-07-25 1981-07-23 GR75287B (enEXAMPLES)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH571580 1980-07-25

Publications (1)

Publication Number Publication Date
GR75287B true GR75287B (enEXAMPLES) 1984-07-13

Family

ID=4298165

Family Applications (1)

Application Number Title Priority Date Filing Date
GR65613A GR75287B (enEXAMPLES) 1980-07-25 1981-07-23

Country Status (23)

Country Link
US (1) US4447431A (enEXAMPLES)
EP (1) EP0045081B1 (enEXAMPLES)
JP (1) JPS5756466A (enEXAMPLES)
KR (13) KR850000883B1 (enEXAMPLES)
AR (1) AR230269A1 (enEXAMPLES)
AT (1) ATE17349T1 (enEXAMPLES)
AU (2) AU7340481A (enEXAMPLES)
CA (1) CA1175431A (enEXAMPLES)
DD (2) DD201677A5 (enEXAMPLES)
DE (1) DE3173434D1 (enEXAMPLES)
DK (1) DK331881A (enEXAMPLES)
ES (8) ES8301472A1 (enEXAMPLES)
FI (1) FI812326L (enEXAMPLES)
GB (1) GB2080805B (enEXAMPLES)
GR (1) GR75287B (enEXAMPLES)
IE (1) IE52071B1 (enEXAMPLES)
IL (1) IL63410A (enEXAMPLES)
NO (1) NO812542L (enEXAMPLES)
NZ (1) NZ197828A (enEXAMPLES)
PL (8) PL237002A1 (enEXAMPLES)
PT (1) PT73424B (enEXAMPLES)
SU (8) SU1235454A3 (enEXAMPLES)
ZA (1) ZA815078B (enEXAMPLES)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2123831B (en) * 1981-07-20 1986-01-15 Ciba Geigy Ag Trisubstituted oxazo compounds
EP0084756A1 (de) * 1982-01-22 1983-08-03 Ciba-Geigy Ag Trisubstituierte Oxazaverbindungen
FR2633291B1 (fr) * 1988-06-27 1990-09-07 Oreal Derives d'hydroxy-4 isoxazoles, leur procede de preparation et compositions cosmetiques et pharmaceutiques les contenant
US5252322A (en) * 1989-09-22 1993-10-12 The Gillette Company Skin tanning compositions containing imidazoles
NZ239161A (en) * 1990-07-31 1994-01-26 Smithkline Beecham Corp Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
US5916891A (en) 1992-01-13 1999-06-29 Smithkline Beecham Corporation Pyrimidinyl imidazoles
MX9300141A (es) * 1992-01-13 1994-07-29 Smithkline Beecham Corp Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
US5670527A (en) * 1993-07-16 1997-09-23 Smithkline Beecham Corporation Pyridyl imidazole compounds and compositions
US5593991A (en) * 1993-07-16 1997-01-14 Adams; Jerry L. Imidazole compounds, use and process of making
US5593992A (en) * 1993-07-16 1997-01-14 Smithkline Beecham Corporation Compounds
WO1995013067A1 (en) * 1993-11-08 1995-05-18 Smithkline Beecham Corporation Oxazoles for treating cytokine mediated diseases
US5723477A (en) * 1994-11-10 1998-03-03 Sibia Neurosciences, Inc. Modulators of acetylcholine receptors
US6369068B1 (en) 1995-06-07 2002-04-09 Smithkline Beecham Corporation Amino substituted pyrimidine containing compounds
US5739143A (en) * 1995-06-07 1998-04-14 Smithkline Beecham Corporation Imidazole compounds and compositions
IL118544A (en) 1995-06-07 2001-08-08 Smithkline Beecham Corp History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
ZA9610687B (en) 1995-12-22 1997-09-29 Smithkline Beecham Corp Novel synthesis.
US6046208A (en) * 1996-01-11 2000-04-04 Smithkline Beecham Corporation Substituted imidazole compounds
NZ327044A (en) * 1996-01-11 2000-01-28 Smithkline Beecham Corp Substituted imidazole compounds
ZA97175B (en) * 1996-01-11 1997-11-04 Smithkline Beecham Corp Novel substituted imidazole compounds.
AP9700912A0 (en) 1996-01-11 1997-01-31 Smithkline Beecham Corp Novel cycloalkyl substituted imidazoles
EP0889888A4 (en) * 1996-03-25 2003-01-08 Smithkline Beecham Corp NEW TREATMENT OF LESIONS IN THE CENTRAL NERVOUS SYSTEM
WO1998007425A1 (en) 1996-08-21 1998-02-26 Smithkline Beecham Corporation Imidazole compounds, compositions and use
US5929076A (en) * 1997-01-10 1999-07-27 Smithkline Beecham Corporation Cycloalkyl substituted imidazoles
TR199902622T2 (xx) * 1997-04-24 2000-05-22 Ortho-Mcneil Pharmaceutical, Inc. Enflamatuvar hastal�klar�n tedavisinde faydal� ikameli imidazoller.
WO1998056377A1 (en) 1997-06-13 1998-12-17 Smithkline Beecham Corporation Novel pyrazole and pyrazoline substituted compounds
US6610695B1 (en) 1997-06-19 2003-08-26 Smithkline Beecham Corporation Aryloxy substituted pyrimidine imidazole compounds
TW517055B (en) 1997-07-02 2003-01-11 Smithkline Beecham Corp Novel substituted imidazole compounds
US7301021B2 (en) * 1997-07-02 2007-11-27 Smithkline Beecham Corporation Substituted imidazole compounds
US6489325B1 (en) 1998-07-01 2002-12-03 Smithkline Beecham Corporation Substituted imidazole compounds
US6562832B1 (en) 1997-07-02 2003-05-13 Smithkline Beecham Corporation Substituted imidazole compounds
AU8381098A (en) 1997-07-02 1999-01-25 Smithkline Beecham Corporation Novel cycloalkyl substituted imidazoles
AR016294A1 (es) * 1997-07-02 2001-07-04 Smithkline Beecham Corp Compuesto de imidazol sustituido, composicion farmaceutica que la contiene, su uso en la fabricacion de un medicamento y procedimiento para supreparacion
EP1041989A4 (en) 1997-10-08 2002-11-20 Smithkline Beecham Corp NEW SUBSTITUTED CYCLOALCENYL COMPOUNDS
AU1924699A (en) 1997-12-19 1999-07-12 Smithkline Beecham Corporation Compounds of heteroaryl substituted imidazole, their pharmaceutical compositionsand uses
CZ20004339A3 (cs) * 1998-05-22 2001-10-17 Smithkline Beecham Corporation Nové 2-alkylem substituované imidazolové sloučeniny
US6858617B2 (en) 1998-05-26 2005-02-22 Smithkline Beecham Corporation Substituted imidazole compounds
WO2000010563A1 (en) * 1998-08-20 2000-03-02 Smithkline Beecham Corporation Novel substituted triazole compounds
ATE258055T1 (de) 1998-11-04 2004-02-15 Smithkline Beecham Corp Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine
WO2000029399A1 (en) * 1998-11-12 2000-05-25 Boehringer Ingelheim (Canada) Ltd. Antiherpes compounds
US6239279B1 (en) 1998-12-16 2001-05-29 Smithkline Beecham Corporation Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives
NZ518032A (en) 1999-11-22 2004-02-27 Smithkline Beecham Plc Substituted imidazole derivatives
US6759410B1 (en) 1999-11-23 2004-07-06 Smithline Beecham Corporation 3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
ES2249309T3 (es) 1999-11-23 2006-04-01 Smithkline Beecham Corp Compuestos de 3,4-dihidro-(1h)quinazolin-2-ona como inhibidores de csbp/p39 kinasa.
ATE296809T1 (de) 1999-11-23 2005-06-15 Smithkline Beecham Corp 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p38-kinase-inhibitoren
ATE281439T1 (de) 1999-11-23 2004-11-15 Smithkline Beecham Corp 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p38-kinase-inhibitoren
US7235551B2 (en) * 2000-03-02 2007-06-26 Smithkline Beecham Corporation 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
AU2001235838A1 (en) * 2000-03-06 2001-09-17 Smithkline Beecham Plc Imidazol derivatives as raf kinase inhibitors
GB0005357D0 (en) 2000-03-06 2000-04-26 Smithkline Beecham Plc Compounds
KR100850812B1 (ko) * 2000-10-23 2008-08-06 스미스클라인 비참 코포레이션 신규 화합물
GB0112348D0 (en) * 2001-05-19 2001-07-11 Smithkline Beecham Plc Compounds
EP1432703A1 (en) * 2001-09-05 2004-06-30 Smithkline Beecham Plc Heterocycle-carboxamide derivatives as raf kinase inhibitors
AU2002361986B2 (en) * 2001-12-18 2008-04-10 F. Hoffmann-La Roche Ag CIS-imidazolines as MDM2 inhibitors
TW200505446A (en) * 2003-01-17 2005-02-16 Fuj Isawa Pharmaceutical Co Ltd Inhibitor of cox
EP1620406A2 (en) * 2003-05-08 2006-02-01 Astellas Pharma Inc. 1,2-diarylimidazoles useful as inhibitors of cox
JP2008537937A (ja) * 2005-03-25 2008-10-02 グラクソ グループ リミテッド ピリド［２，３−ｄ］ピリミジン−７−オンおよび３，４−ジヒドロピリミド［４，５−ｄ］ピリミジン−２（１Ｈ）−オン誘導体の製造方法
PE20100737A1 (es) * 2005-03-25 2010-11-27 Glaxo Group Ltd Nuevos compuestos
WO2013049272A2 (en) * 2011-09-29 2013-04-04 Theraceutix, Llc Composition and method for treatment of symptoms associated with various skin conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558645A (en) * 1968-07-08 1971-01-26 Sandoz Ag 2-(4-(4',5-diphenyl - 2 - imidazolyl)-phenoxy) lower aliphatic monocarboxylic acids
CH561718A5 (enEXAMPLES) * 1971-05-10 1975-05-15 Ciba Geigy Ag
GB1469532A (en) * 1973-06-28 1977-04-06 Dumex Ltd As Imimdazolyl-alkanoic acid derivatives
US4372964A (en) * 1980-10-30 1983-02-08 E. I. Du Pont De Nemours And Company Antiinflammatory 4,5-diaryl-1H-imidazole-2-methanols

Also Published As

Publication number Publication date
KR850000885B1 (ko) 1985-06-26
PL232352A1 (enEXAMPLES) 1982-12-20
PL135822B1 (en) 1985-12-31
IE811680L (en) 1982-01-25
KR850002747A (ko) 1985-05-15
KR850000888B1 (ko) 1985-06-26
CA1175431A (en) 1984-10-02
KR850002746A (ko) 1985-05-15
ES514582A0 (es) 1983-05-16
ZA815078B (en) 1982-07-28
ES8306124A1 (es) 1983-05-16
DD201677A5 (de) 1983-08-03
SU1152520A3 (en) 1985-04-23
NZ197828A (en) 1985-11-08
KR850002755A (ko) 1985-05-15
ES514585A0 (es) 1983-07-01
KR850002744A (ko) 1985-05-15
KR850000889B1 (ko) 1985-06-26
ES8306122A1 (es) 1983-05-16
EP0045081B1 (de) 1986-01-08
KR850001064B1 (ko) 1985-07-25
SU1138023A3 (ru) 1985-01-30
JPS5756466A (en) 1982-04-05
ES514584A0 (es) 1983-05-16
ATE17349T1 (de) 1986-01-15
ES8306120A1 (es) 1983-05-16
SU1145928A3 (ru) 1985-03-15
KR850000911B1 (ko) 1985-06-27
FI812326A7 (fi) 1982-01-26
GB2080805B (en) 1984-03-07
ES514579A0 (es) 1983-05-16
ES8307245A1 (es) 1983-07-01
KR850002745A (ko) 1985-05-15
IE52071B1 (en) 1987-06-10
ES8306123A1 (es) 1983-05-16
ES504257A0 (es) 1982-12-01
KR850002754A (ko) 1985-05-15
PL236997A1 (en) 1983-01-03
SU1235454A3 (ru) 1986-05-30
KR850002750A (ko) 1985-05-15
US4447431A (en) 1984-05-08
PT73424B (en) 1983-06-20
ES514583A0 (es) 1983-05-16
KR830006230A (ko) 1983-09-20
ES8301472A1 (es) 1982-12-01
SU1205764A3 (ru) 1986-01-15
IL63410A0 (en) 1981-10-30
KR850002749A (ko) 1985-05-15
KR850002753A (ko) 1985-05-15
KR850000886B1 (ko) 1985-06-26
KR850002752A (ko) 1985-05-15
EP0045081A3 (en) 1982-04-07
KR850000891B1 (ko) 1985-06-26
KR850000883B1 (ko) 1985-06-26
ES8306119A1 (es) 1983-05-16
AR230269A1 (es) 1984-03-01
GB2080805A (en) 1982-02-10
PT73424A (en) 1981-08-01
KR850002756A (ko) 1985-05-15
KR850000887B1 (ko) 1985-06-26
EP0045081A2 (de) 1982-02-03
IL63410A (en) 1986-04-29
PL237003A1 (en) 1983-02-28
AU5655586A (en) 1986-09-11
PL237004A1 (en) 1983-02-28
ES514581A0 (es) 1983-05-16
ES514580A0 (es) 1983-05-16
KR850000873B1 (ko) 1985-06-22
AU7340481A (en) 1982-01-28
NO812542L (no) 1982-01-26
KR850002748A (ko) 1985-05-15
KR850000890B1 (ko) 1985-06-26
ES8306121A1 (es) 1983-05-16
SU1227112A3 (ru) 1986-04-23
KR850000884B1 (ko) 1985-06-26
PL237002A1 (en) 1983-02-28
SU1169534A3 (ru) 1985-07-23
PL237005A1 (en) 1983-02-28
DD202554A5 (de) 1983-09-21
SU1205763A3 (ru) 1986-01-15
PL237000A1 (en) 1983-02-28
DE3173434D1 (en) 1986-02-20
FI812326L (fi) 1982-01-26
DK331881A (da) 1982-01-26
PL237001A1 (en) 1983-02-28
KR850000892B1 (ko) 1985-06-26

Similar Documents

Publication Publication Date Title
FR2480365B1 (enEXAMPLES)
FR2481554B1 (enEXAMPLES)
FR2480480B1 (enEXAMPLES)
FR2481465B1 (enEXAMPLES)
CH663511GA3 (enEXAMPLES)
FR2479480B1 (enEXAMPLES)
FR2478872B1 (enEXAMPLES)
FR2482140B3 (enEXAMPLES)
FR2478544B2 (enEXAMPLES)
FR2473820B1 (enEXAMPLES)
FR2473810B1 (enEXAMPLES)
FR2474195B1 (enEXAMPLES)
FR2475309B1 (enEXAMPLES)
FR2474126B1 (enEXAMPLES)
FR2480870B1 (enEXAMPLES)
FR2478376B1 (enEXAMPLES)
FR2481118B1 (enEXAMPLES)
FR2476687B1 (enEXAMPLES)
FR2480497B1 (enEXAMPLES)
FR2476808B1 (enEXAMPLES)
FR2478379B3 (enEXAMPLES)
FR2480033B1 (enEXAMPLES)
FR2477845B1 (enEXAMPLES)
FR2480685B1 (enEXAMPLES)
FR2479878B1 (enEXAMPLES)